Suppr超能文献

一种来自板栗的新型多糖:制备、特性及其体内外抗肿瘤活性

A novel polysaccharide from Castanea mollissima Blume: Preparation, characteristics and antitumor activities in vitro and in vivo.

作者信息

Dong Xiao-Dan, Feng Ying-Ying, Liu Yi-Ning, Ji Hai-Yu, Yu Sha-Sha, Liu Anjun, Yu Juan

机构信息

College of Food Engineering and Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China; QingYunTang Biotech (Beijing) Co., Ltd., No. 14, Zhonghe Street, Beijing Economic-Technological Development Area, Beijing 100176, China.

College of Food Engineering and Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.

出版信息

Carbohydr Polym. 2020 Jul 15;240:116323. doi: 10.1016/j.carbpol.2020.116323. Epub 2020 Apr 20.

Abstract

A new water-soluble polysaccharide, CMP90, with a molecular weight of 23.9 kDa was isolated from Castanea mollissima Blume and the preliminary structural characteristics and antitumor effects of CMP90 in vitro and in vivo were investigated in the research. CMP90 consists of arabinose, galactose, glucose, xylose and mannose (molar ratio: 0.08:0.11:5.14:0.12:0.08) with α- and β-anomeric units. The results of in vitro experiments indicated that CMP90 exhibited a significant inhibitory effect on the proliferation of HL-60 cells with typical apoptotic characteristics by inducing cell cycle arrested at G1/M phase. Additionally, the results in vivo suggested CMP90 was able to inhibit the growth of S180 solid tumors via protecting immune organs, improving the levels of serum cytokines (TNF-α, IL-2 and IFN-γ), enhancing the activities of immune cells (macrophages, lymphocytes and NK cells) and inducing cell apoptosis or death. Taken together, these combined data clearly indicated that CMP90 may be used as a potential candidate agent for cancer therapy.

摘要

从板栗中分离出一种新的水溶性多糖CMP90,其分子量为23.9 kDa,并对其体外和体内的初步结构特征及抗肿瘤作用进行了研究。CMP90由阿拉伯糖、半乳糖、葡萄糖、木糖和甘露糖组成(摩尔比:0.08:0.11:5.14:0.12:0.08),含有α-和β-异头物单元。体外实验结果表明,CMP90通过诱导细胞周期阻滞在G1/M期,对HL-60细胞的增殖具有显著抑制作用,并具有典型的凋亡特征。此外,体内实验结果表明,CMP90能够通过保护免疫器官、提高血清细胞因子(TNF-α、IL-2和IFN-γ)水平、增强免疫细胞(巨噬细胞、淋巴细胞和NK细胞)活性以及诱导细胞凋亡或死亡来抑制S180实体瘤的生长。综上所述,这些综合数据清楚地表明,CMP90可能作为一种潜在的癌症治疗候选药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验